Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 11:31 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1777–1800 of 2,210 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Reduced Activity Clear all

Conditions: Radiation Retinopathy
Interventions: 0.5 mg ranibizumab, Targeted Retinal Photocoagulation (TRP); Drug · Procedure
Lead sponsor: Greater Houston Retina Research; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 4
States / cities: Dallas, Texas • Houston, Texas • Katy, Texas + 1 more

Conditions: Sexual Violence
Interventions: Bystander & Sexual Violence Prevention, General Health Promotion; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 24 Years · Male only
Enrollment: 743 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Diabetes Mellitus, Type 2
Interventions: Virta Health; Behavioral
Lead sponsor: Colorado Prevention Center; Other
Eligibility: 18 Years to 79 Years
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 3
States / cities: Craig, Colorado • Lamar, Colorado • Salida, Colorado

Conditions: Ehlers-Danlos Syndrome, Healthy Subjects
Interventions: ML1101 Stimulus Isolator, Cardiowatch Bracelet; Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Asthma
Interventions: Active Air Purifier, Placebo Air Purifier; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 8 Years to 17 Years
Enrollment: 198 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Loudness Hyperacusis, Autism Spectrum Disorder (ASD), Hyperacusis
Interventions: Transitional Intervention for Hyperacusis in Autism; Other
Lead sponsor: University of Central Florida; Other
Eligibility: 18 Years to 39 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Orlando, Florida • Dallas, Texas

Conditions: Chronic Kidney Disease
Interventions: L-Arginine, Placebo; Drug · Other
Lead sponsor: The University of Texas at Arlington; Other
Eligibility: 35 Years to 75 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 2
States / cities: Newark, Delaware • Dallas, Texas

Conditions: Insomnia, Alcohol Use Disorder
Interventions: Cognitive Behavioral Therapy for Insomnia, Sleep Hygiene, Alcohol Use Disorder Treatment as Usual; Behavioral
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years and older
Enrollment: 67 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Infant Environmental Tobacco Smoke Exposure
Interventions: Motivational Interviewing intervention, Usual Care, Usual Care - Reduced Measurement; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 12 Years and older
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Houston, Texas

Conditions: HIV, Sexual Risk, Sexually Transmitted Diseases, Substance Abuse, Violence, Victimization
Interventions: Test, Treat, Retain(TTR) + Women's Health CoOp (WHC), Test, Treat, Retain(TTR) only; Behavioral · Biological
Lead sponsor: RTI International; Other
Eligibility: 15 Years to 55 Years · Female only
Enrollment: 641 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Research Triangle Park, North Carolina

Conditions: Nicotine Addiction, Panic Attack
Interventions: d-cycloserine, Pill Placebo, Nicotine replacement therapy, Panic and Smoking Reduction Treatment; Drug · Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 65 Years
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Cardiovascular Diseases
Interventions: Nutrition, Exercise, Stress Management Counseling, usual care; Behavioral · Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 45 Years to 75 Years
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2029
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: PreDiabetes
Interventions: PAC with HEPA filter intact, PAC with HEPA filter removed; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 85 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: White Coat Hypertension, Hypertension, Blood Pressure, Anxiety, Virtual Reality Exposure Therapy, Ambulatory Blood Pressure Monitoring, Blood Pressure Disorders
Interventions: Virtual Reality Exposure; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Tinnitus
Interventions: Coping Effectiveness Training, Cognitive-behavioral therapy, Acceptance and Commitment Therapy; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Obesity, Overweight
Interventions: Semaglutide 1.0 mg, Semaglutide 2.4 mg, Placebo I (Semaglutide), Placebo II (Semaglutide); Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 1,210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 50
States / cities: Buena Park, California • Concord, California • Fresno, California + 42 more

Conditions: Hiv, Alcohol Problem
Interventions: Alcohol Brief Intervention (BI), Common Elements Treatment Approach (CETA) via Telemedicine; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 99 Years
Enrollment: 308 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Substance Use Disorder (SUD), Recovery
Interventions: EMA Only, EMI Only, EMA+EMI, Neither - RSAU; Other
Lead sponsor: Chestnut Health Systems; Other
Eligibility: 18 Years and older
Enrollment: 401 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 3
States / cities: Chicago, Illinois • Normal, Illinois

Conditions: Depressive Disorder
Interventions: Interpersonal Psychotherapy for Depressed Adolescents, Selective Serotonin Reuptake Inhibitor, Usual Care; Behavioral · Drug · Other
Lead sponsor: University of Minnesota; Other
Eligibility: 12 Years to 18 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Obstructive Sleep Apnea (OSA), Snoring, Sleep Quality
Interventions: Exercise; Other
Lead sponsor: Case Western Reserve University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Hiv, Chlamydia, Gonorrhea
Interventions: all2GETHER; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 16 Years to 34 Years
Enrollment: 5,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Depression, Anxiety Disorders and Symptoms
Interventions: Amplification of Positivity Training (6 Sessions), Stress Management Training (6 Sessions); Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 55 Years
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Alcohol Use Disorder (AUD)
Interventions: Zonisamide, Placebo; Drug
Lead sponsor: Washington State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 205 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Spokane, Washington

Conditions: Pain, Back Pain, Low Back Pain, Chronic Pain, Neck Pain
Interventions: STEPPT Pilot, Standard Care (Control); Behavioral
Lead sponsor: San Diego State University; Other
Eligibility: 18 Years and older
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: San Diego, California

Search by objective public record fields.

Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy.

A Web-based Bystander Education Program

Virta Intervention in CommuniTies in cOloRado (VICTOR-Pilot)

ABVN Phase 2 - EDS Wearable Device

AIRWEIGHS: Investigating Obesity as a Susceptibility Factor for Air Pollution in Childhood Asthma

Transitional Intervention for Hyperacusis in Autism

L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients

CBT-I on Alcohol Treatment Outcomes Among Veterans

Reducing Environmental Tobacco Smoke in Neonatal Intensive Care Unit (NICU) Infants' Homes

WHC+ (Women's Health CoOp PLUS)

Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine

Novel Strategies for Reducing Heart Disease Risk Disparities

Cleaner Air for Lower Cardiometabolic Risk

Virtual Reality as a Tool to Lower Blood Pressure and Anxiety in Clinic Settings

A Comparison of Three Psychoeducational Group Interventions for Veterans With Tinnitus

Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity

Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA

Using Smartphones to Provide Recovery Support Services

An Adaptive Algorithm-Based Approach to Treatment for Adolescent Depression

The Impact of Technology in Obstructive Sleep Apnea Myofunctional Therapy

Effectiveness of Relationship Education for Reducing HIV Incidence Among Men Who Have Sex With Men

Amplification of Positivity to Enhance Social Connections in Anxiety and Depression

The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study

Development of STEPPT